T1	Condition 35 41	cancer
E1	Condition:T1 Name:T50
T2	Age 52 55	age
E2	Age:T2 Eq-Comparison:E3
T3	Eq-Comparison 56 66	1-18 years
E3	Eq-Comparison:T3 Value:T51 Operator:T52 Value:T53 Temporal-Unit:T54
T5	Eq-Comparison 75 83	received
E5	Eq-Comparison:T5 Temporal-Period:T55
T6	Procedure 94 103	treatment
E6	Procedure:T6 Temporality:E5
T7	Drug 119 132	anthracycline
E7	Drug:T7 Name:T56
T8	Or 133 139	and/or
E8	Or:T8 Arg:E7 Arg2:E9
T9	Drug 140 156	alkylating agent
E9	Drug:T9 Name:T57
T10	Procedure 157 169	chemotherapy
E10	Procedure:T10 Name:T58
T11	Condition 176 184	Diseases
E11	Condition:T11 Name:T59
T12	Risk 222 226	risk
E12	Risk:T12 Polarity:T60 Risk-For:E15
T13	Or 227 229	or
E13	Or:T13 Arg:E12 Arg2:E14
T14	Risk 240 244	risk
E14	Risk:T14 Polarity:T61 Risk-For:E15
T15	Condition 251 273	lymphoblastic leukemia
E15	Condition:T15 Name:T63 Severity:T62
T16	Condition 281 297	myeloid leukemia
E16	Condition:T16 Name:T65 Severity:T64
T17	Condition 299 315	Hodgkin lymphoma
E17	Condition:T17 Name:T66
T18	Modifier 321 328	Hodgkin
E18	Modifier:T18 Modifies:T67
T19	Condition 329 337	lymphoma
E19	Condition:T19 Name:T67
T20	Condition 339 347	sarcomas
E20	Condition:T20 Name:T68
T21	Condition 349 356	Healthy
E21	Condition:T21 Name:T69
T22	Condition 369 376	Healthy
E22	Condition:T22 Name:T70
T23	Age 410 414	ages
E23	Age:T23 Eq-Comparison:E24
T24	Eq-Comparison 415 425	1-18 years
E24	Eq-Comparison:T24 Value:T72 Operator:T73 Value:T74 Temporal-Unit:T75
T25	Condition 448 456	diseases
E25	Condition:T25 Name:T76
T26	Or 457 459	or
E26	Or:T26 Arg:E25 Arg2:E28
T28	Condition 460 478	medical conditions
E28	Condition:T28 
T29	Assertion 484 492	might be
E29	Assertion:T29 Asserted:T77 Asserted2:T78
A1	Assertion-Type-Value E29 hypothetical
T30	Or 505 507	or
E30	Or:T30 Arg:T77 Arg2:T78
T31	Study 540 545	study
E31	Study:T31 Stability:T78
T32	Condition 547 554	Healthy
E32	Condition:T32 Name:T79
T35	Assertion 693 696	can
E35	Assertion:T35 Asserted:T81
A3	Assertion-Type-Value E35 hypothetical
T36	Observation 708 728	epigenetic signature
E36	Observation:T36 Name:T27 Stability:T81
T37	Observation 779 784	blood
E37	Observation:T37 Specimen:T82
T39	Procedure 808 820	routine care
E39	Procedure:T39 Name:T33
T40	Condition 842 848	Cancer
E40	Condition:T40 Name:T83
T41	Eq-Comparison 880 888	received
E41	Eq-Comparison:T41 Temporal-Period:T84
T42	Procedure 891 913	bone marrow transplant
E42	Procedure:T42 Name:T85 Temporality:E41
T43	Negation 919 922	not
E43	Negation:T43 Negates:E42
T44	Condition 936 943	Healthy
E44	Condition:T44 Name:T86
T46	Or 1045 1047	or
E46	Or:T46 Arg:T87 Arg2:E47
T47	Modifier 1048 1055	chronic
E47	Modifier:T47 Modifies:T88
T48	Condition 1056 1063	disease
E48	Condition:T48 Name:T88 Severity:T87
T49	Negation 1072 1080	excluded
E49	Negation:T49 Negates:E48
T50	Condition-Name 35 41	cancer
T51	Eq-Value 56 57	1
T52	Eq-Operator 57 58	-
A4	Eq-Operator-Value T52 BETWEEN
T53	Eq-Value 58 60	18
T54	Eq-Temporal-Unit 61 66	years
A5	Eq-Temporal-Unit-Value T54 year
T55	Eq-Temporal-Period 75 83	received
A6	Eq-Temporal-Period-Value T55 past
T56	Drug-Name 119 132	anthracycline
T57	Drug-Name 140 156	alkylating agent
T58	Procedure-Name 157 169	chemotherapy
T59	Condition-Name 176 184	Diseases
T60	Polarity 217 221	high
A7	Polarity-Value T60 high
T61	Polarity 235 239	high
A8	Polarity-Value T61 high
T62	Severity 245 250	acute
A9	Severity-Value T62 severe
T63	Condition-Name 251 273	lymphoblastic leukemia
T64	Severity 275 280	acute
A10	Severity-Value T64 severe
T65	Condition-Name 281 297	myeloid leukemia
T66	Condition-Name 299 315	Hodgkin lymphoma
T67	Condition-Name 329 337	lymphoma
T68	Condition-Name 339 347	sarcomas
T69	Condition-Name 349 356	Healthy
T70	Condition-Name 369 376	Healthy
T71	Life-Stage-And-Gender 401 409	children
A11	Life-Stage-And-Gender-Type T71 child
T72	Eq-Value 415 416	1
T73	Eq-Operator 416 417	-
A12	Eq-Operator-Value T73 BETWEEN
T74	Eq-Value 417 419	18
T75	Eq-Temporal-Unit 420 425	years
A13	Eq-Temporal-Unit-Value T75 year
T76	Condition-Name 448 456	diseases
T77	Stability 493 501	affected
A14	Stability-Value T77 change
T78	Stability 516 522	impact
A15	Stability-Value T78 change
T79	Condition-Name 547 554	Healthy
T81	Stability 697 703	affect
A16	Stability-Value T81 change
T82	Observation-Specimen 779 784	blood
T83	Condition-Name 842 848	Cancer
T84	Eq-Temporal-Period 880 888	received
A17	Eq-Temporal-Period-Value T84 past
T85	Procedure-Name 891 913	bone marrow transplant
T86	Condition-Name 936 943	Healthy
T87	Severity 1039 1044	acute
A18	Severity-Value T87 severe
T88	Condition-Name 1056 1063	disease
T89	Life-Stage-And-Gender 25 34	Childhood
A19	Life-Stage-And-Gender-Type T89 child
T4	And 71 74	who
E4	And:T4 Arg:E2 Arg2:E6
R1	Using Arg1:E6 Arg2:E7	
R2	Using Arg1:E10 Arg2:E7	
R3	Using Arg1:E10 Arg2:E9	
R4	Example-Of Arg1:E15 Arg2:E11	
R5	Example-Of Arg1:E16 Arg2:E11	
R6	Example-Of Arg1:E17 Arg2:E11	
T90	Negation 317 320	non
E50	Negation:T90 Negates:E18
R7	Example-Of Arg1:E19 Arg2:E11	
R8	Example-Of Arg1:E20 Arg2:E11	
R9	Equivalent-To Arg1:T71 Arg2:E22	
T91	Negation 438 447	free from
E51	Negation:T91 Negates:E25 Negates2:E28
T92	And 430 433	who
E52	And:T92 Arg:E23 Arg2:E51
R10	Caused-By Arg1:T78 Arg2:E25	
R11	Caused-By Arg1:T78 Arg2:E28	
T27	Observation-Name 708 728	epigenetic signature
T33	Procedure-Name 808 820	routine care
R12	Using Arg1:E39 Arg2:E37	
